Taken together, these findings suggest a positive feedback loop among VDR, EGFR, and FASN in NSCLC cells, and disrupting this loop may alleviate NSCLC EGFR-TKI resistance. The gene discussed is FASN; the disease is non-small cell lung carcinoma.